Research grant

Helsinn invites the submission of proposals for research studies in line with its therapeutic areas of interest. At Helsinn’s discretion, research support for such studies may be provided.

Mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL)

Proposals that advance clinical knowledge on novel uses; support for case study reports will also be considered.

Chemotherapy-induced nausea and vomiting (CINV)

Proposals focused on advancing CINV prophylaxis and treatment including nausea control, breakthrough/refractory use, orally administered cancer therapies, or use with immunotherapy combined with either moderately emetogenic chemotherapy or highly emetogenic chemotherapy.

Privacy Statement

The provision of personal data by you may be necessary where in our legitimate interest in order for us to provide you with the requested services and for the performance of any contractual relationship with you. Because of our commitment to the protection of your personal data, we evaluate our privacy policies and procedures to implement improvements and refinements from time to time. Please read the Privacy and Cookies Policy carefully in order to understand our views and practices regarding your personal data and how we will treat it. The Privacy Policy is also a part of our Terms of Use for the Website.